The CDC Grant Funding Profiles site provides interactive data and summaries of CDC cooperative agreement and grant funding to recipients in U.S. states and territories, and the District of Columbia, starting with fiscal year (FY) 2010. The data is compiled in a format that allows users to view, sort, and analyze funding data by funding opportunity announcement, funding source (CDC funding category and sub-category), geography, and recipient name and type.
CDC’s Public Health Infrastructure Center is pleased to announce the launch of the Public Health Infrastructure Grant’s (PHIG’s) Health Department recipient profiles. The profiles provide policymakers, legislators, public health partners, and the general public with an important view of CDC’s historic investment in public health infrastructure. The data visualizations showcase how the more than $3.6 billion investment towards infrastructure will impact 107 health departments (50 states, Washington D.C., 8 territories/freely associated states, and 48 large localities).
On June 23, 2023, NASTAD held a webinar, “HIV Data Privacy, Criminalization, and the Role of Health Departments.” This webinar provided an overview of NASTAD’s newly updated resource “U.S. HIV Data Protection Landscape,” including trends and findings from a comprehensive 53-jurisdiction review of HIV data privacy laws and regulations, followed by a discussion with two guest speakers about the role of health departments and legal counsel in upholding and strengthening HIV data protections.
Watch this panel discussion with Hep B United partners about the work they’re doing on the ground, the challenges they’re facing in their communities, and the strategies they’re employing to ensure hepatitis B awareness, education, screening, vaccination, and treatment are reaching those who need it.
This video discusses how any new prisoner to the country’s 17 penitentiaries sees a psychiatrist, a doctor and if needed is offered to join a treatment programme. Comprehensive harm reduction services not only include drug dependence treatment but also needle syringe exchange and HIV testing and treatment. HIV prevalence is 11% among people who inject drugs in Moldova vs 0.36% among the general population. They are one of the most affected groups in the country. UNAIDS, UNODC and WHO have been long-time supporters of expanding these services to all prisons.
This factsheet discusses how it is estimated that on any given day, there are at around 11 million people in prison. Prisons and other closed settings have a high prevalence of HIV, hepatitis B and C and tuberculosis (TB) infections.
This video discusses how Daouda Diouf comes daily to the Fann Hospital compound daily in Dakar, Senegal. He is one of 250 people enrolled in CEPIAD’s opioid substitution therapy programme (OST). OST is a globally recognized intervention to reduce injecting behaviors that put people who inject drugs at risk of contracting HIV and other blood-borne diseases, such as viral hepatitis.
This fact sheet discusses how mpox can spread to anyone through close (often skin-to-skin) contact. This includes intimate contact (kissing, touching, any kind of sex). If your partner has mpox, avoid sex or being intimate until all sores have healed and a fresh layer of skin has formed.
This fact sheet discusses how mpox is a rare but potentially serious disease that is caused by the mpox virus. The mpox virus is from the same family of viruses as the smallpox virus. The symptoms of mpox are similar to smallpox symptoms, but are less severe. It is also less transmissible than smallpox, and rarely fatal. The mpox virus can spread from infected humans, animals, and materials contaminated with the virus. The mpox virus is characterized by a new unexplained rash and skin lesions.
One of four pre-recorded video presentations on the current landscape of U.S. government-supported mpox research. The highlighted research efforts include Phase III clinical trials of tecovirimat (TPOXX) to treat mpox.
